Phagenesis Ltd

Phagenesis Ltd is dedicated to transforming the treatment of dysphagia through innovative medical device technology. Phagenesis is committed to helping individuals worldwide regain their ability to enjoy meals and live life to the fullest. The company is at the forefront of dysphagia care, providing a revolutionary approach to improving swallowing function.

Phagenesis has developed Phagenyx, a pioneering product utilizing Pharyngeal Electrical Stimulation (PES) to treat dysphagia. This non-invasive device stimulates the nerves in the pharynx, empowering patients to regain control of their swallowing. Rigorous clinical trials have demonstrated that Phagenyx significantly enhances swallowing ability in patients suffering from dysphagia. The primary address of Phagenesis Ltd is Enterprise House, Manchester, M15 6SE, GB.

Committed to advancing dysphagia care, Phagenesis works closely with healthcare providers and patients, ensuring the highest standards of safety and efficacy. Phagenesis Ltd continues to lead the way in changing the paradigm of dysphagia care, improving the lives of millions globally. We invite the management of Phagenesis Ltd to create a customized and exclusive company showcase and product listing on our platform to further highlight their innovative contributions.